Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
- 22 February 2013
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 31 (4), 967-974
- https://doi.org/10.3892/ijmm.2013.1285
Abstract
In the present study, we investigated the anticancer effects of sodium butyrate (NaBu) on hepatocellular carcinoma (HCC) cells in vitro. As a histone deacetylase (HDAC) inhibitor, NaBu upregulated Ac-H3 and inhibited HDAC4 protein expression in a time- and dose-dependent manner. MTT assays showed that treatment with NaBu at high concentrations significantly inhibited the growth of various HCC cells. Exposure to NaBu for 24 h induced cell cycle arrest in the SMMC-7721 and HepG2 cells. NaBu also induced the apoptosis of SMMC‑7721 cells. The expression levels of cell cycle- and apoptosis-related proteins were further investigated by western blot analysis using specific antibodies. The results provided a possible mechanism responsible for the inhibitory effects of NaBu on the growth of HCC cells. To further analyze the role of NaBu in cell migration, wound healing and Transwell assays were performed, indicating that NaBu significantly inhibits cell migration/invasion in HCC cells. Transforming growth factor-β1 (TGF-β1)-induced epithelial to mesenchymal transition (EMT) has been associated with tumor cell migration and invasion. The EMT markers, E-cadherin, vimentin and N-cadherin, were regulated by TGF-β1, while NaBu inhibited this process in which HDAC4 and matrix metalloproteinase (MMP)7 may be involved. Based on our findings, we propose that NaBu may be useful as an anticancer drug for HCC therapy.Keywords
This publication has 40 references indexed in Scilit:
- Class II Histone Deacetylases Downregulate GLUT4 Transcription in Response to Increased cAMP Signaling in Cultured Adipocytes and Fasting MiceDiabetes, 2012
- Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasiaNature Medicine, 2012
- c-MET Protects Breast Cancer Cells from Apoptosis Induced by Sodium ButyratePLOS ONE, 2012
- Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerasesHepatology, 2011
- The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinomaHepatology, 2011
- Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer CellsPLOS ONE, 2011
- microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicityBritish Journal of Cancer, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organJCI Insight, 2007
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004